*Corresponding Author:
K. Saenphet
Research Center in Bioresources for Agriculture, Industry and Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
E-mail: stit.lilo123@gmail.com
Date of Accepted 20 May 2020
Date of Revised 23 April 2020
Date of Received 21 July 2019
Indian J Pharm Sci 2020;82(3):508-514  

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms


The present study aims to investigate the antiinflammatory activity of the slime extracts from the giant African snail, Lissachatina fulica. In this study, aqueous and ethanol extracts of the snail slime were evaluated for antiinflammatory activities in vitro. The aqueous extract showed greater antiinflammatory activities than that of the ethanol extract. The aqueous extract was further tested for antiinflammatory activity in vivo. For acute inflammation, the ear edema assay was used to screen the slime extract. The results revealed that application of 2 mg/ear extract or phenylbutzone could significantly reduce edema when compared with ethanol-treated ears. For chronic inflammatory test, the cotton pellet granuloma model was employed to determine the activity of the slime extract. It was found that 2.5 and 6.25 % extract could significantly reduce transudative and granuloma weights. Moreover, the extracts also reduced malondialdehyde and increased superoxide dismutase in the granuloma tissue of the induced rats. In conclusion, the slime extract showed antiinflammatory activity both in vitro and in vivo. The antiinflammatory activity was also observed against acute and chronic inflammations, which suggested that the slime extracts has the potential to be developed into antiinflammatory products.


Antiinflammatory activity, giant African snail, Lissachatina fulica, slime extract

Inflammation is a common response to detrimental stimuli such as irritants, pathogens or damaged cells. The outcomes of inflammatory reaction are stimuli elimination and tissue repair [1]. Although inflammation is a beneficial strategy, the progression of the inflammatory process often causes unwanted outcomes such as pain, swelling, redness and loss of function of inflamed cells or even oxidative stress. Non-steroidal antiinflammatory drugs (NSAIDs) were developed to relieve these inflammatory symptoms, especially pain. Unfortunately, treatment of inflammation with NSAIDs produces negative side effects, for instance stomach irritation and cardiovascular problems [2,3]. Recently, natural products that have antiinflammatory properties have become an alternative way to relieve these symptoms. There are several scientific reports about antiinflammatory properties of natural products, mainly from medicinal plants, but there are not many about animal product.

Snail slime is a secretory fluid produced from mucus glands located in the skin including the foot plate. It is mainly used to reduce friction and protect its foot during locomotion. Moreover, carnivorous slug or shell-less snail secrete slime to maintain moisture and to help their mating and hunting activities [4]. Snail slime has become a remarkable ingredient in cosmetic products because it contains some biochemical substances, which have properties useful to skin care, such as alantoin, elastin, collagen and hyaluronic acid [5]. Furthermore, the slime has also been reported to have pharmacological activities including antibacterial activity [6,7], antioxidant and regenerative properties [8] and anticancer property [9]. Interestingly, the slime extracted from Achatina fulica has been reported to heal incised wounds faster than self-healing can [10]. In the wound healing process, the healing stages start after inflammatory products and dead cells were cleared out of the wound site [10,11]. Therefore, inflammation is an important stage, which directly affects the healing process. Due to the ability to accelerate wound healing, snail slime was assumed to have antiinflammatory activity. However, there is no scientific evidence for the antiinflammatory activity of snail slime. Therefore, the aim of this study was to evaluate the antiinflammatory activity of slime from the giant African snail (Lissachatina fulica) using various in vitro and in vivo methods.

Materials and Methods

Snail collection, identification, Slime collection and extraction:

Thirty African snails (adult stage) were collected from Chiang Mai, Thailand. These land snails were morphologically identified according to Bouchet et al. [12]. Snails were stimulated to secrete slime by putting them on a plate, which was immersed in warm water (32°). The snails were scrubbed and then the slime was squeezed out from the snail body. The slime was collected and extracted with distilled water and ethanol. The slime was mixed with each solvent and stirred for 1 h and then centrifuged at 3500 rpm for 10 min. Supernatants of the slime were collected, lyophilized as aqueous and ethanol extracts (yield 7.0 and 1.4 mg extract/ml slime, respectively).

Evaluation of in vitro antiinflammatory activity, antiproteinase activity:

This test was done according to a modified method of Oyedepo et al. [13] and Sakat et al. [14]. Two millilitres reaction mixture (0.06 mg trypsin, 1 ml of 20 mM pH 7.4 Tris HCl buffer and 1 ml of the sample) was incubated at 37° for 5 min, then 1 ml of 0.8 % casein was added and incubated again for 20 min, 2 ml of 70 % perchloric acid was added and then the cloudy suspension was centrifuged. The absorbance of the supernatant was measured at 210 nm, and sodium salicylate was used as a reference standard. The obtained absorbance was converted to percent antiproteinase activity using the Eqn. 1, % inhibition = [(Abs control-Abs test)/(Abs control)]×100.

Antilipoxygenase activity:

Antilipoxygenase activity of extracts was evaluated using the method described by Shinde et al. [15]. The sample was prepared by dissolving the extract in 2 M borate buffer (pH 9.0), 0.25 ml of prepared sample was mixed with 0.25 ml of lipoxidase (20000 u/ml) and incubated at 25° for 5 min. After that, 1.0 ml of 0.6 mM linoleic acid was added, mixed well and absorbance was measured at 234 nm and % antilipoxygenase activity was calculated using Eqn. 1. In this test, indomethacin was used as a reference standard.

Inhibition of protein denaturation:

This assay was conducted according to the method of Kumari et al. [16]. The reaction mixture contained 0.2 ml of egg albumin, 2.8 ml PHS (pH 6.4) and 2 ml of extract was incubated at 37° for 15 min and heated at 70° for 5 min. After cooling to room temperature, absorbance of a sample was measured at 660 nm on a spectrophotometer. Percent inhibition of protein denaturation was calculated using Eqn, 1. Sodium salicylate was used as a reference standard.

Membrane stabilization:

Antihaemolytic activity was determined to find out the ability of the extracts to stabilize membranes. The procedure used was as described by Shinde et al. [15]. In this assay, red blood cells (RBC) suspension was prepared from the blood collected from rats (without NSAIDs), washed 3 times by centrifugation at 3000 rpm for 30 min with normal saline. The pellet was resuspended to make a 10 % RBC suspension for the experiment. In the antihaemolytic test, 1 ml of 10 % RBC suspension was mixed with 1 ml of the sample, heated at 56° for 30 min, cooled down under running tap water and centrifuged at 2500 rpm for 10 min. The absorbance of the supernatant was measured at 560 nm. Percent antihaemolysis activity was calculated from Eqn. 1. In this study, indomethacin was used as a reference drug.

In vivo antiinflammatory study:

Male Wistar rats (Rattus norvegicus) were purchased from the National Laboratory Animal Center, Salaya, Nakhon Pathom, Thailand. The rats were housed in a controlled room, 25±1° under 12 h light/dark cycle, with free access to water and food, for 7 d to acclimate. The experimental protocol used in this study was reviewed and approved by the Institutional Animal Care and Use Committee of the Biology Department, Faculty of Science, Chiang Mai University, Thailand (ID: Re 009/17).

Ethyl phenyl propiolate (EPP)-induced ear edema assay:

The procedure used in this assay was modified from the method of Kale et al. [17]. Male Wistar rats, weighing 35-40 g, were used in this study. Before treating, their ear thickness was measured with automatic Vernier calipers. Then, 2 doses of aqueous extract of snail slime (1 mg/ear and 2 mg/ear) and phenylbutazone (1 mg/ear), dissolved in 20 μl of 50% ethanol (vehicle) were applied on both inner and outer left ears. Also, the vehicle was topically applied to the right ears (the negative control) in the same manner. Ear edema was then immediately induced by topical application of 5 % EPP and ear thickness was measured after induction at 15, 30, 60 and 120 min. Percent inhibition of edema (% EDI) = (EDC-EDT)/EDC×100, where, EDC is the oedema of control group obtained from ear thickness at X min-ear thickness at 0 min, EDT is the oedema of test, ear thickness at X min-ear thickness at 0 min.

Cotton pellet-induced granuloma model:

The method used in the study was the method reported by Agrawal et al. [18] with a slight modification. Twenty male Wistar rats, weighing 180-200 g, were randomly divided into 4 groups (5 rats per group). The rats were anesthetized with intramuscular injections of thiopental. Four sterilized cotton pellets (50±1 mg) were subcutaneously implanted on the back of the anesthetized rats (axillae and groin regions) with an aseptic technique. Two hours after the implantation, those rats were treated topically with aqueous extract of snail slime, 50 % ethanol (vehicle) and diclofenac (standard). The treatment was given once a day for 7 d. On day 8, the pellets were dissected and weighed (wet weight), then they were dried at 60° for 24 h and weighed again (dry weight). Percent inhibition of transudate and granuloma formations were calculated from wet and dry weights, respectively. Furthermore, the granuloma tissue was processed into histological slides stained with H&E and Masson’s trichrome to observe leukocyte infiltration and fibrosis. The tissue was also examined for oxidative stress through measurement of malondialdehyde (MDA) level and superoxide dismutase (SOD) activity, which represent lipid peroxidation and antioxidant enzyme, respectively.

Evaluation of oxidative stress of granuloma tissue:

The granuloma tissue (20 mg) was homogenized in 1 ml of 0.1 M Tris-HCl buffer pH 7.4 and centrifuged at 3000 rpm for 10 min at 4°. The supernatant was collected for MDA and SOD measurement.

MDA level measurement:

The procedures followed the method of Uchiyama and Mihara [19]. About 100 μl of the sample (collected supernatant) was pipetted into a screw cap tube, then 450 μl of normal saline, 100 μl thiobarbituric acid and 1000 μl of 10 % trichloroacetic acid we collected and mixed them well. The mixture was incubated at 100° for 30 min and then cooled down under running tap water. Distilled water was added into the incubated solution, mixed well, and the mixture was centrifuged at 3000 rpm for 10 min. The supernatant was measured for absorbance at 532 nm. The obtained absorbance was compared with the standard curve of tetramethoxypropane, and the MDA level was calculated from the standard curve and represented it as nmol/mg protein.

Measurement of SOD activity:

The SOD activity was examined with a method modified from Takada et al. [20]. About 100 μl of the sample (collected supernatant) was combined with 1 ml reaction solution (0.1 mM Na2-EDTA, 0.025 mM nitroblue tetrazolium, and 3 mM xanthine and 60 mM sodium carbonate buffer). Then 100 μl of xanthine oxidase was added and mixed well. The absorbance was measured at 560 nm every minute for 5 min. The SOD activity was calculated from the absorbance and standard curve, and represented as unit/mg protein.

Statistical analysis:

Statistical analysis was performed using Statistical Package for the Social Sciences version 17. P value <0.05 was considered statistically significant.

Results and Discussion

The slime extract showed antiproteinase activity, and the aqueous extract had a significantly higher effect than the ethanol extract. The aqueous extracts (1000 μg/ml) could inhibit proteinase activity up to 70.81±0.40 %, while the ethanol extract, at the same concentration, could inhibit only 43.27±0.23 %. Sodium salicylate (standard) was quite effective and caused 72.65 ±0.44 % inhibition at 70 μg/ml concentration.

In this study, it was found that the snail slime extracts had antilipoxygenase activity. The aqueous and ethanol extracts (1000 μg/ml) exhibited 37.19±3.15 and 33.88±2.77 % inhibition, respectively, which was not significant, while indomethacin inhibited up to 68.60±0.96 % at 70.93 μg/ml concentration.

The protein denaturation inhibitory activity of snail slime extracts was detected in both aqueous and ethanol extracts. Both extracts displayed inhibitory activities, though the aqueous extract exhibited significantly better performance than the ethanol extract (41.99±2.37 and 12.76±3.61 % at the concentration of 1000 μg/ml). Indomethacin also inhibited denaturation; it could produce 41.82±13.85 % inhibition at the concentration of 1000 μg/ml concentration.

Both snail slime extracts had a slight effect on membrane stabilization. The aqueous and ethanol extracts could reduce haemolysis of red blood cells, this was reflected in the percentage of inhibitions (7.01±0.54 and 13.42±0.28 %, respectively, at the concentration of 1000 μg/ml). Indomethacin displayed highly effective antihemolytic activity; 100 μg/ml of indomethacin generated 23.15±4.13 % of inhibition.

From in vitro study, it was found that the aqueous extract showed better activity than the ethanol extract. The aqueous extract was therefore selected to study further in in vivo models of acute and chronic inflammation. Snail slime extract reduced EPP-induced ear oedema at all time points studied as shown in Table 1. The slime extract (2 mg/ear) at 60 and 120 min after oedema induction and phenylbutazone (1 mg/ear) at 30, 60 and 120 min after oedema induction showed significant inhibition relative to vehicle-treated ears. The slime extract at a dose of 1 mg/ear could also reduce ear oedema, but this was not significant compared with the vehicle-treated ears.

Treatment Ear oedema thickness (µm)
0 min 15 min EDI (%) 30 EDI (%) 60 EDI (%) 120 EDI (%)
Neg (right) 394±10 446±26 - 466±10 - 435±17 - 437±20 -
PHE (left) 397±30 422±14 51.92 423±24* 60.57 399±10* 94.62 406±10* 74.56
Neg (right) 405±13 444±25 - 452±23 - 433±11 - 427±19 -
E1 (left) 392±20 426±10 12.82 429±14 21.27 413±15 25.00 411±10 13.64
Neg (right) 406±20 436±13 - 449±20 - 455±22 - 450±19 -
E2 (left) 397±16 418±25 15.45 422±19 42.79 411±10* 71.14 410±10* 70.10

Table 1: Effect of Slime Extracts on Epp-Induced Ear Edema in Rat

The slime extract could significantly decrease both transudate and granuloma weights when compared to negative control group (p<0.05, Table 2). Diclofenac also significantly decreased the transudate and granuloma weights and compared to negative control group.

  Transudate weight (mg) % Inhibition of transudate Granuloma weight (mg) % Inhibition of granuloma
Neg 577.12±46.86 - 99.94±12.87 -
Diclofenac 297.96±21.65* 48.37 47.13±5.76* 52.84
E2.5 433.17±25.76* 24.94 78.28±5.23* 21.68
E6.25 411.74±21.49* 28.64 73.68±6.74* 26.28

Table 2: Effect of Slime Extracts on Cotton Pellet-Induced Granuloma in Rats

H and E staining showed dense leukocyte infiltration and fibroblast and collagen formation in the granuloma tissue of untreated rats (fig. 1). These features normally occur during inflammation. Granuloma tissues treated with diclofenac showed only a few scattered leukocytes and fibroblasts. Treatment with the slime extract showed decreased leukocyte infiltration compared with untreated rats, and showed fibroblast cells and collagen deposition. From Masson’s trichrome stain, there was plenty of collagen formulated in the granuloma tissue of untreated rats as shown in fig. 2a. Treatment of slime extracts and diclofenac could reduce collagen deposition in granuloma tissue, as shown in fig. 2b-d.


Figure 1: Histopathology section of granuloma tissue (H&E stain 20X)
= fibroblast cell. (a) Negative control group, (b) diclofenac, (c) slime extract (2.5 %) and (d) slime extract (6.25 %). (a) The section in negative control group displayed severe inflammation with dense leukocytes and collagen formation. (b) The section of granuloma tissue in diclofenac-treated group showed mild inflammation with few leukocytes and fibroblasts. (c and d) The granuloma section in groups treated with slime extract both doses showing moderate inflammation with decreasing inflammatory cells


Figure 2: Histopathology section of granuloma tissue (Masson’s trichrome stain 20X)
(a) Negative control group, (b) diclofenac, (c) slime extract (2.5 %) and (d) slime extract (6.25 %). (a) The section in the negative control group revealed thick collagen deposition (indicated in blue) during granuloma formation. (b) The section for the diclofenactreated group showed light collagen deposition during granuloma formation. (c and d) The granuloma section in groups treated with slime extracts, both doses, showed collagen synthesis in the 2 groups were lower than that of the negative control

From MDA measurement of granuloma tissue, it was found that the MDA level of granuloma tissue from rats treated with vehicle, diclofenac, 2.5 % and 6.25 % slime extract were, 1.13±0.052, 0.88±0.053, 0.96±0.010 and 0.92±0.175 nmol/mg protein, respectively. These results showed that the extracts significantly reduced MDA levels compared to the negative control group (p<0.05; fig. 3a). SOD measurement indicated that the SOD activity of granuloma tissue from rats treated with vehicle, diclofenac, 2.5 % and 6.25 % slime extract were 20.37±10.25, 52.48±12.57, 44.90±7.35 and 61.11±7.91 unit/mg protein/min, respectively. These results showed that the slime extract and diclofenac significantly increased SOD activity when compared to untreated rats (fig. 3b).


Figure 3: Effect of treatments MDA levels and SOD activity of granuloma tissue
Each column represent mean±SD (n=5), *represents significant difference (p<0.05) when compared with negative control

The inflammatory process involves a complex series of events, for instance the release of mediators and enzymes; leukocyte migration; and extravascular fluid accumulation [21]. The results of this study indicated that snail slime extracts could ameliorate these inflammatory events due to thier antiinflammatory activity. From in vitro study, the slime extracts showed mechanisms of action through different pathways, including inhibitions of inflammatory enzymes, membrane stabilization and antiprotein denaturation. Diclofenac used as standard references in in vitro, also displayed antiinflammatory activity in every assay.

An EPP-induced ear edema test was used to verify antiinflammatory activity against acute inflammation in the aqueous extract, in vivo. Topical application of EPP causes release of the inflammatory mediators, histamine, serotonin, bradykinin and prostaglandins. These mediators promote vascular permeability, vasodilation and accumulation of fluid in tissues, which lead to ear edema [22,23]. In this study, high dose of slime extract could significantly reduce ear thickness indicating that the slime extract had antiinflammatory properties and the mechanism of action might be through inhibiting the mediators of the acute phase of inflammation. Phenylbutazone used in the experiment, also inhibited the induced ear oedema and showed higher efficacy than both doses of the extract. Phenylbutazone is an inhibitor of cyclooxygenase, which decreased amplification of the inflammatory signals, leading to decreased inflammation. Slime extract and phenylbutazone generated highest % inhibition at 60 min, raising the possibility that the main mechanism of action of the slime extract is related to inhibition of cyclooxygenase.

Chronic inflammation occurs when the acute inflammatory response cannot eliminate the harmful stimuli. The chronic response is divided into two phases; the transudative/exudative phase and the proliferative phase. The transudative phase is the initial phase, characterized by increased vascular permeability and vascular protein leakage [24]. The proliferative is the later phase, in which granuloma tissue is formed that is characterized by leukocyte infiltration, fibroblast proliferation, collagen formation and angiogenesis [24,25]. In the cotton pellet-induced granuloma assay, the wet weight of the cotton pellet was used to determine transudate volume, and the dry weight of the cotton pellet was used to evaluate granuloma formation [26]. In present study, slime extract showed antiinflammatory activity in both phases. In the transudative phase, the result indicated an inhibitory effect of the slime extract on vascular permeability, vasodilation and accumulation of extravascular fluid. In the proliferative phase, the snail slime extract could inhibit granuloma formation, which was shown by reduction in granuloma weight. Histopathology of granuloma showed the decreasing of inflammatory cell and collagen deposition in the granuloma tissues of the slime extract treated groups. It was clear that the slime extract affected to the formation of granuloma tissue. This suggested the inhibitory activity of the extract on leukocyte migration and collagen formation at site of inflammation. This might have been due to the ability of the slime extract to decrease the inflammatory signals that enhance the granuloma formation. It was reported that extracts from snails could decrease plasma IL-6, an inflammatory cytokine in osteoarthritis-induced dog [27] and decrease COX level induced in inflammatory keratinocytes [28]. In the study, the slime extracts also improved the oxidative status of cotton-pellet induced granuloma in rats. This effect might have been due to its antioxidant properties. The previous study found that this snail slime had SOD activity and had antilipidperoxidation activity [29]. Thus, it is possible that antioxidant activity might be another mechanism of action in the slime extract to improve inflammatory status.

The results of the present study demonstrated the in vitro and in vivo antiinflammatory activity of slime extracted from giant African snails (Lissachatina fulica). Thus it could be concluded that the snail slime extracts have antiinflammatory activity with potential to be developed as antiinflammatory products. Although this study revealed some mechanisms of action of the slime extracts, further study is necessary to probe it’s activity in different models.


Authors would like to thank the Science Achievement Scholarship of Thailand, the Department of Biology in the Faculty of Science at Chiang Mai University and the Graduate school, Chiang Mai University. This research work was partially supported by Chiang Mai University and Research Center in Bioresources for Agriculture, Industry and Medicine, Chiang Mai University.